Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
77 participants
OBSERVATIONAL
2020-04-30
2022-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Retrospective, Blinded Validation of a Host-response Based Diagnostics
NCT01911143
COVID-10 in the Pediatric Population: SARS-CoV-2 Seropositivity
NCT04690114
Febrile Infant Diagnostic Assessment and Outcome Study
NCT05259683
Viral Dynamics of Omicron in Children
NCT05240183
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Other information about finances, mental health, and nutrition will be ascertained by questionnaires. The subjects will be asked to allow the researchers to abstract information from their medical record, participate in an interview or telephone call (their choice) to answer questionnaires, and to provide a stool sample at three time points.
The creation of an integrated database of COVID-19 pediatric and young adult patients will better inform the pediatric hematology, oncology, and stem cell transplant community about this disease specifically related to patients undergoing HOT therapy and provide valuable evidence to develop standardized and clinically appropriate approaches to their care.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Heme/Non-Sickle Cell Disease
Subjects with a diagnosis of hemoglobinapathy except Sickle Cell Disease
No interventions assigned to this group
Heme/Sickle Cell Disease
Subjects with a diagnosis of Sickle Cell Disease
No interventions assigned to this group
Neuro-Oncological Disease
Oncology diagnosis with involvement of the neurological system
No interventions assigned to this group
Oncology/Non-Neuro-Oncological
Subjects with any oncology diagnosis except those that involve the neurological system.
No interventions assigned to this group
Transplant patients
Subjects who have received or are intending to have a stem cell transplant for treatment of disease.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Tested for COVID-19
* Age up to 21 years of age
Exclusion Criteria
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Columbia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Prakash Satwani, MD
Role: PRINCIPAL_INVESTIGATOR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Columbia University Irving Medical Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AAAT0268
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.